Dr. Yupeng Ren 任宇鹏
Chief Physician
Department of Colorectal Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of colorectal tumors, including sphincter-preserving rectal cancer surgery, minimally invasive procedures, and rare tumors such as neuroendocrine tumors and stromal tumors.
Dr. Ren holds a PhD in Oncology and serves as Chief Physician in the Colorectal Surgery Department at Liaoning Cancer Hospital & Institute. Since 1978, Dr. Ren has focused on clinical care and research for colorectal tumors. Publications include four SCI papers and three Chinese core journal articles as first or corresponding author, plus one co-authored book.
Professional roles
- Member, Rapid Rehabilitation Group, Abdominal Tumor Professional Committee, China Medicine Education Association
- Member, Youth Group, Northeast Three Provinces Parenteral and Enteral Nutrition Support Professional Committee
Name order: in Chinese the family name comes first (Ren Yupeng). Papers usually list the name as Yupeng Ren or Ren Y.
Selected publications
9 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Transl Med, 2026 (senior author): ST3GAL1 drives colorectal cancer metastasis by mediating NRF2-induced activation of the integrin-α6β4 signaling pathway via sialylation modification. PubMed 41904587
- Cancer Med, 2020 (senior author): Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. PubMed 31743579
- Exp Ther Med, 2019 (first author): MicroRNA-761 is downregulated in colorectal cancer and regulates tumor progression by targeting Rab3D. PubMed 30783458
- J Sep Sci, 2019 (senior author): Determination of multi-class antibiotic residues in compost by microwave-enhanced accelerated solvent extraction and ultra performance convergence chromatography with tandem mass spectrometry. PubMed 30644644
- Biol Res, 2018 (first author): MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1. PubMed 30474556
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion